Donor graft perfusion pre-transplant prolongs xenograft survival
Henry, M.L.; Bendle, M.D.
Transplantation Proceedings 28(2): 595
1996
ISSN/ISBN: 0041-1345 PMID: 8623291 Document Number: 463778
Document emailed within 1 workday
Related Documents
Parikh, Y.; Toledo-Pereyra, L.H.; Finkelstein, I.; Bandlien, K.; Castellanos, J.; Mittal, V. 1987: Prolonged pancreas transplant survival following graft donor pretreatment with cyclosporine a or concanavalin a Transplantation Proceedings 19(5): 4336-4339Zhou, M.; Chen, D.; Yao, Q.; Xia, Z.; Wang, C.; Zhu, H. 1998: Microencapsulation of rat islets prolongs xenograft survival in diabetic mice Chinese Medical Journal 111(5): 394-397
Blakely, M.L.; Van der Werf, W.J.; Stuhlmeier, K.; Dalmasso, A.P.; Winkler, H.; Bach, F.H. 1994: Retinoic acid inhibits expression of E-selectin in endothelial cells and prolongs discordant xenograft survival Transplantation Proceedings 26(3): 1176
Greenstein, S.M.; Sun, S.C.; Senitzer, D.; Schechner, R.S.; Tellis, V.A. 1993: Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation Transplantation Proceedings 25(1 Part 1): 490-491
Kamei, T.; Callery, M.P.; Flye, M.W. 1989: Intravenous and portal venous administration of modified donor antigen prolongs rat parathyroid allograft survival Surgery 106(6): 1028-1034; Discussion: 1034-1035
Lussow, A.R.; Fanget, L.; Gao, L.; Buelow, R.; Pouletty, P. 1996: Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival Transplantation Proceedings 28(2): 571-572
Kumar, M.S.; Stephan, R.; Chui, J.; Chvala, R.P.; Olshan, A.; Krevolin, L.; Abouna, G.M. 1993: Effect of donor age on graft function and graft survival in cadaver renal transplantation Transplantation Proceedings 25(3): 2183-2184
Eriksson, T.; Riesbeck, K.; Ostraat, O.; Ekberg, H.; Björkman, S. 1992: Drug exposure and flow cytometry analyses in a thalidomide treatment schedule that prolongs rat cardiac graft survival Transplantation Proceedings 24(6): 2560-2561
Donaldson, P.T.; Thomson, L.J.; Heads, A.; Underhill, J.A.; Vaughan, R.W.; Rolando, N.; Williams, R. 1995: IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry Transplantation 60(9): 1016-1023
Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343
Orlowski, J.P.; Spees, E.K. 1993: Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months Transplantation Proceedings 25(1 Part 2): 1535
Busquets, J.; Xiol, X.; Figueras, J.; Jaurrieta, E.; Torras, J.; Ramos, E.; Rafecas, A.; Fabregat, J.; Lama, C.; Ibañez, L.; Llado, L.; Ramon, J.M. 2001: The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival Transplantation 71(12): 1765-1771
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1996: Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion Transplantation Proceedings 28(6): 3269
Martin, S.; Dyer, P.A.; Mallick, N.P.; Gokal, R.; Johnson, R.W. 1987: Transplant-induced donor-specific antibodies and graft outcome Transplantation Proceedings 19(1 Part 1): 899
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Tokunaga, Y.; Zaima, M.; Tanaka, K.; Yamamoto, Y.; Sakai, Y.; Ueda, J.; Ozaki, N.; Yamaoka, Y.; Ozawa, K. 1989: Effects of perfusion temperature on donor graft viability in canine orthotopic partial liver transplantation Transplantation Proceedings 21(1 Part 2): 1296-1298
Wetzels, J.F.; Hoitsma, A.J.; Koene, R.A. 1986: Influence of cadaver donor age on renal graft survival Clinical Nephrology 25(5): 256-259
Cicciarelli, J.; Iwaki, Y.; Mendez, R. 1999: The influence of donor age on kidney graft survival in the 1990s Clinical Transplants 1999: 335-340
Barrero Candau, R.; Morcillo Azcárate, J.; Fernández Hurtado, M.; García Merino, F.; de Agustín Asensio, J.C. 2010: Results of living donor kidney transplant in pediatric recipients, with graft obtained by laparoscopy Cirugia Pediatrica: Organo Oficial de la Sociedad Espanola de Cirugia Pediatrica 23(3): 141-143